The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2023
Filed:
Jan. 11, 2019
Applicant:
Sage Therapeutics, Inc., Cambridge, MA (US);
Inventors:
Albert Jean Robichaud, Boston, MA (US);
Francesco G. Salituro, Marlborough, MA (US);
Maria Jesus Blanco-Pillado, Arlington, MA (US);
Daniel La, Chestnut Hill, MA (US);
Boyd L. Harrison, Princeton Junction, NJ (US);
Assignee:
Sage Therapeutics, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); A61K 31/382 (2006.01); A61K 31/385 (2006.01); A61K 31/39 (2006.01); A61K 31/435 (2006.01); A61K 31/498 (2006.01); A61K 31/502 (2006.01); A61K 31/517 (2006.01); A61K 31/53 (2006.01); A61K 31/536 (2006.01); A61K 31/415 (2006.01); C07D 221/08 (2006.01); C07D 237/26 (2006.01); C07D 239/70 (2006.01); C07D 241/36 (2006.01); C07D 253/08 (2006.01); C07D 265/02 (2006.01); C07D 265/12 (2006.01); C07D 265/34 (2006.01); C07D 279/02 (2006.01); C07D 279/08 (2006.01); C07D 279/14 (2006.01); C07D 291/08 (2006.01); C07D 311/78 (2006.01); C07D 319/02 (2006.01); C07D 319/08 (2006.01); C07D 319/14 (2006.01); C07D 323/04 (2006.01); C07D 327/06 (2006.01); C07D 327/10 (2006.01); C07D 335/04 (2006.01); C07D 339/08 (2006.01); C07D 341/00 (2006.01); C07D 401/06 (2006.01); C07D 405/14 (2006.01); C07D 407/14 (2006.01); C07D 409/14 (2006.01); C07D 411/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 419/14 (2006.01); C07J 73/00 (2006.01);
U.S. Cl.
CPC ...
C07J 73/003 (2013.01);
Abstract
Provided herein is a compound of Formula (I-I), or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I-I), and methods of using the compounds, e.g. in the treatment of CNS-related disorders.